| Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment D Mongan, M Ramesar, M Föcking, M Cannon, D Cotter Early intervention in psychiatry 14 (4), 385-397, 2020 | 98 | 2020 |
| Development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence D Mongan, M Föcking, C Healy, SR Susai, M Heurich, K Wynne, B Nelson, ... JAMA psychiatry 78 (1), 77-90, 2021 | 69 | 2021 |
| Prevalence of self-reported mental disorders in pregnancy and associations with adverse neonatal outcomes: a population-based cross-sectional study D Mongan, J Lynch, D Hanna, C Shannon, S Hamilton, C Potter, ... BMC pregnancy and childbirth 19, 1-10, 2019 | 50 | 2019 |
| Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study HJ Jones, MC Borges, R Carnegie, D Mongan, PJ Rogers, SJ Lewis, ... The Lancet Psychiatry 8 (12), 1062-1070, 2021 | 40 | 2021 |
| Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis M Heurich, M Föcking, D Mongan, G Cagney, DR Cotter Molecular psychiatry 27 (1), 127-140, 2022 | 36 | 2022 |
| Peripheral complement proteins in schizophrenia: a systematic review and meta-analysis of serological studies D Mongan, S Sabherwal, SR Susai, M Föcking, M Cannon, DR Cotter Schizophrenia research 222, 58-72, 2020 | 36 | 2020 |
| The association between specific types of childhood adversity and attenuated psychotic symptoms in a community sample D Mongan, C Shannon, D Hanna, A Boyd, C Mulholland Early intervention in psychiatry 13 (2), 281-289, 2019 | 32 | 2019 |
| Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort D Mongan, C Healy, HJ Jones, S Zammit, M Cannon, DR Cotter Translational Psychiatry 11 (1), 321, 2021 | 24 | 2021 |
| COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders D Mongan, M Cannon, DR Cotter Brain, behavior, and immunity 88, 9, 2020 | 17 | 2020 |
| Association of complement and coagulation pathway proteins with treatment response in first-episode psychosis: a longitudinal analysis of the OPTiMiSE Clinical Trial SR Susai, M Föcking, D Mongan, M Heurich, F Coutts, A Egerton, ... Schizophrenia bulletin 49 (4), 893-902, 2023 | 10 | 2023 |
| Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort JF Byrne, C Healy, D Mongan, SR Susai, S Zammit, M Fӧcking, ... Translational Psychiatry 12 (1), 377, 2022 | 10 | 2022 |
| Omega‐3 fatty acid in ultra‐high‐risk psychosis: A systematic review based on functional outcome SR Susai, S Sabherwal, D Mongan, M Föcking, DR Cotter Early intervention in psychiatry 16 (1), 3-16, 2022 | 10 | 2022 |
| European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) High Risk Study Group. Development of proteomic prediction models for … D Mongan, M Föcking, C Healy JAMA psychiatry 78 (1), 77-90, 2021 | 10 | 2021 |
| Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: A nested case-control study D Mongan, SR Susai, M Föcking, JF Byrne, S Zammit, M Cannon, ... Brain, Behavior, and Immunity 111, 90-100, 2023 | 9 | 2023 |
| Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical … SR Susai, C Healy, D Mongan, M Heurich, JF Byrne, M Cannon, ... Translational psychiatry 12 (1), 454, 2022 | 8 | 2022 |
| Broadening the parameters of clinical high risk for psychosis D Cotter, C Healy, L Staines, D Mongan, M Cannon American Journal of Psychiatry 179 (9), 593-595, 2022 | 7 | 2022 |
| Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal JF Byrne, D Mongan, J Murphy, C Healy, M Fӧcking, M Cannon, ... Translational Psychiatry 13 (1), 333, 2023 | 5 | 2023 |
| Machine learning based prediction and the influence of complement–Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial SR Susai, D Mongan, C Healy, M Cannon, G Cagney, K Wynne, JF Byrne, ... Brain, behavior, and immunity 103, 50-60, 2022 | 5 | 2022 |
| The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial SR Susai, D Mongan, C Healy, M Cannon, B Nelson, C Markulev, ... Brain, behavior, and immunity 99, 147-156, 2022 | 4 | 2022 |
| Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms C Healy, J Byrne, SR Suasi, M Föcking, D Mongan, E Kodosaki, ... Brain, Behavior, and Immunity 117, 175-180, 2024 | 3 | 2024 |
